Kimmel Cancer Center at the Jefferson Breast Cancer Symposium features latest in research, treatment

Current article ratings:
Patients / public:healthcare Prof:
The latest advances in the treatment of breast cancer and research including innovations in Diagnostics, surgery, chemotherapy and radiation are approaches Friday, April 8, 2011, be discussed at a breast cancer Symposium at the Kimmel Cancer Center at Jefferson in Philadelphia.

The full-day, breast cancer Symposium, part of an annual series at the Kimmel Cancer Center, is on the Bluemle life sciences building, 233 S. 10th Street, starts at 8:30 pm place

"Breast cancer is a multi-disciplinary effort, with input from a variety of specialists, such as pathologists, surgeons, radiation oncologists and medical oncologists, who decide on treatment and care," Richard Pestell, m.d., says PhD., Director of the Kimmel Cancer Center at the Jefferson and Professor and Chair of cancer biology at the Jefferson Medical College of Thomas Jefferson University.

"This symposium is that for the next generation of Therapeutics in women with breast cancer a opportunity for the players together to come to highlight the innovative discoveries which we believe will be important," he adds.

A number of issues is covered here by top experts in the Jefferson and other institutions in the United States.

Michael Lisanti, m.d., Professor of cancer biology at the Jefferson Medical College, discuss the recent work with new models for cancer, "the reverse Warburg effect" and "the Autophagic tumor stroma model of cancer." His studies have shown, as mitochondrial oxidative stress plays a role in cancer development and how cancer metabolism predict is used clinical results.

"High risk patients with breast cancer, those whose Krebszellen use high energy metabolites can be treated with new Therapeutics, the mitochondrial oxidative metabolism aim," said Dr. Lisanti. "We should reconsider, with antioxidants and Autophagy inhibitors as anti-cancer agents."

Also, there are presentations by Hallgeir Rui, m.d., Ph.d., of the Department of cancer biology at the Jefferson Medical College, therapy relevant stratification of breast cancer is to the topic and Paula Ryan, m.d., PhD., Fox Chase Cancer Center's Department of medical oncology, a clinical update on patients with triple negative breast cancer, one will present disease, high-risk characterized as aggressive and respond less to standard treatment.

Hyman B. must, MD, which results in the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill School of medicine, a session titled "Geriatics: to treat older people with breast cancer."

Sixty percent of the cancer in the United States occurs in persons at the age of 65 and older. At the same time possibly senior patients acute or chronic diseases, which make their sophisticated cancer treatment. To address these specific challenges, the Kimmel Cancer Center has therefore at the Jefferson the new, multidisciplinary Senior Adult Oncology Center provide for senior patients in a comprehensive consultation established thereby.

Source: Thomas Jefferson University